BACKGROUND: Diabetes predicts late-life dementia, but the association with rate of cognitive decline is inconsistent and has rarely been examined in non-white populations, despite the high prevalence of diabetes in African Americans. We evaluated the effect of diabetes on cognitive decline in middle-aged African Americans and whites. METHODS: Atherosclerosis Risk in Communities (ARIC) Brain MRI Study participants (n = 1,886, mean age = 60, 49% African American) underwent assessments of verbal memory, processing speed, and verbal fluency four times over 14 years. Using race-stratified mixed linear effects models, we examined cognitive change for participants with prevalent (baseline) diabetes and incident (diagnosed after baseline) diabetes versus those without diabetes. RESULTS: African Americans had more advanced diabetes, as indicated by fasting blood glucose levels, anti-diabetes medication use, and cardiovascular risk profiles. African Americans with prevalent diabetes experienced 41% greater annual decline in processing speed scores (p = 0.048) and 50% greater annual decline in verbal fluency scores (p = 0.042) than those without diabetes; incident diabetes was not associated with cognitive decline. Among whites, diabetes was not associated with cognitive decline. CONCLUSIONS: Prevalent diabetes was associated with greater cognitive decline in middle-aged African Americans, possibly reflecting adverse effects of longer duration and more advanced diabetes.
BACKGROUND:Diabetes predicts late-life dementia, but the association with rate of cognitive decline is inconsistent and has rarely been examined in non-white populations, despite the high prevalence of diabetes in African Americans. We evaluated the effect of diabetes on cognitive decline in middle-aged African Americans and whites. METHODS:Atherosclerosis Risk in Communities (ARIC) Brain MRI Study participants (n = 1,886, mean age = 60, 49% African American) underwent assessments of verbal memory, processing speed, and verbal fluency four times over 14 years. Using race-stratified mixed linear effects models, we examined cognitive change for participants with prevalent (baseline) diabetes and incident (diagnosed after baseline) diabetes versus those without diabetes. RESULTS: African Americans had more advanced diabetes, as indicated by fasting blood glucose levels, anti-diabetes medication use, and cardiovascular risk profiles. African Americans with prevalent diabetes experienced 41% greater annual decline in processing speed scores (p = 0.048) and 50% greater annual decline in verbal fluency scores (p = 0.042) than those without diabetes; incident diabetes was not associated with cognitive decline. Among whites, diabetes was not associated with cognitive decline. CONCLUSIONS: Prevalent diabetes was associated with greater cognitive decline in middle-aged African Americans, possibly reflecting adverse effects of longer duration and more advanced diabetes.
Authors: Loes C Lanting; Inez M A Joung; Johan P Mackenbach; Steven W J Lamberts; Aart H Bootsma Journal: Diabetes Care Date: 2005-09 Impact factor: 19.112
Authors: T H Mosley; D S Knopman; D J Catellier; N Bryan; R G Hutchinson; C A Grothues; A R Folsom; L S Cooper; G L Burke; D Liao; M Szklo Journal: Neurology Date: 2005-06-28 Impact factor: 9.910
Authors: J R Cerhan; A R Folsom; J A Mortimer; E Shahar; D S Knopman; P G McGovern; M A Hays; L D Crum; G Heiss Journal: Gerontology Date: 1998 Impact factor: 5.140
Authors: Geert Jan Biessels; Mark W J Strachan; Frank L J Visseren; L Jaap Kappelle; Rachel A Whitmer Journal: Lancet Diabetes Endocrinol Date: 2013-10-18 Impact factor: 32.069
Authors: Anna Marseglia; Anna K Dahl Aslan; Laura Fratiglioni; Giola Santoni; Nancy L Pedersen; Weili Xu Journal: J Gerontol A Biol Sci Med Sci Date: 2018-03-02 Impact factor: 6.053
Authors: Elizabeth Rose Mayeda; Eric J Tchetgen Tchetgen; Melinda C Power; Jennifer Weuve; Hélène Jacqmin-Gadda; Jessica R Marden; Eric Vittinghoff; Niels Keiding; M Maria Glymour Journal: Am J Epidemiol Date: 2016-08-30 Impact factor: 4.897
Authors: Jeffrey F Scherrer; John E Morley; Joanne Salas; James S Floyd; Susan A Farr; Sascha Dublin Journal: Ann Fam Med Date: 2019-07 Impact factor: 5.166
Authors: Hugh C Hendrie; Mengjie Zheng; Kathleen A Lane; Roberta Ambuehl; Christianna Purnell; Shanshan Li; Frederick W Unverzagt; Michael D Murray; Ashok Balasubramanyam; Chris M Callahan; Sujuan Gao Journal: Alzheimers Dement Date: 2018-04-18 Impact factor: 21.566
Authors: Elizabeth R Mayeda; Mary N Haan; Kristine Yaffe; Alka M Kanaya; John Neuhaus Journal: Alzheimer Dis Assoc Disord Date: 2015 Jul-Sep Impact factor: 2.703
Authors: Shaoxun Wang; Wenshan Lv; Huawei Zhang; Yedan Liu; Longyang Li; Joshua R Jefferson; Ya Guo; Man Li; Wenjun Gao; Xing Fang; Ian A Paul; Grazyna Rajkowska; James P Shaffery; Thomas H Mosley; Xinlin Hu; Ruen Liu; Yangang Wang; Hongwei Yu; Richard J Roman; Fan Fan Journal: Geroscience Date: 2020-07-21 Impact factor: 7.713
Authors: Kumar B Rajan; Zoe Arvanitakis; Elizabeth B Lynch; Elizabeth A McAninch; Robert S Wilson; Jennifer Weuve; Lisa L Barnes; Antonio C Bianco; Denis A Evans Journal: Neurology Date: 2016-09-21 Impact factor: 9.910
Authors: Priya Palta; Michelle C Carlson; Rosa M Crum; Elizabeth Colantuoni; A Richey Sharrett; Sevil Yasar; Richard L Nahin; Steven T DeKosky; Beth Snitz; Oscar Lopez; Jeff D Williamson; Curt D Furberg; Stephen R Rapp; Sherita Hill Golden Journal: J Gerontol A Biol Sci Med Sci Date: 2017-12-12 Impact factor: 6.053